Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : GILD save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.16 130
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.7918 7.85% 220K
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $3.25 1.25% 42K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
gilead first sciences financial results
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published: 2024-04-08 (Crawled : 13:30) - prnewswire.com
RDHL | $0.4227 -4.45% 270K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -1.5%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
biopharma results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
RMD | $183.42 1.7% 380K
|
Health Technology
|
| O: 0.88%
H: 1.64%
C: 0.03%
LUNG | $7.5 1.35% 43K
|
Health Technology
|
| O: 0.59%
H: 1.64%
C: -7.13%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.12%
H: 0.24%
C: -1.54%
financial
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -1.0%
business year pipeline therapeutics financial results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $49.35 0.43% 1.4M
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.36 0.61% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.19 0.47% 360K
|
Health Technology
| Email alert
Add to watchlist
GMAB | News | $28.82 -0.52% 120K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.5 0.74% 450K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | News | $289.67 5.3K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.965 1.24% 890K
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
ASMB | $12.99 -1.74% 8.8K
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.36 0.61% 1.2M
|
Health Technology
| Email alert
Add to watchlist
year financial results
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
XLO | $1.085 -1.36% 180K
|
Professional, Scientific, and T...
|
| O: 200.47%
H: 0.52%
C: -43.75%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
million therapeutics
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
XLO | $1.085 -1.36% 180K
|
Professional, Scientific, and T...
|
| O: 200.47%
H: 0.52%
C: -43.75%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
il-12 license program agreement
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
Published: 2024-03-27 (Crawled : 23:00) - prnewswire.com
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.33%
H: 0.85%
C: 0.0%
year financial results
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
DHR | $252.325 6.88% 2.6M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
ABT | News | $107.565 0.46% 610K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
VIR | $8.145 0.56% 180K
|
Health Technology
|
| O: 0.4%
H: 2.3%
C: 0.9%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.7%
H: 0.19%
C: 0.12%
hepatitis diagnostics market
Gilead Sciences Announces Completion of Acquisition of CymaBay
Published: 2024-03-22 (Crawled : 22:00) - biospace.com/
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
acquisition sciences
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.741 4.81% 480K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -5.19%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
pharma business year financial results
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published: 2024-03-18 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
BAX | $40.755 0.88% 450K
|
Health Technology
|
| O: 0.02%
H: 1.03%
C: 0.96%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.11%
H: 0.59%
C: 0.1%
BIIB | $194.93 0.42% 210K
|
Health Technology
|
| O: -0.48%
H: 0.31%
C: 0.13%
reach cancer treatment global market
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
Published: 2024-03-06 (Crawled : 15:30) - biospace.com/
MRUS | $40.985 1.32% 140K
|
Health Technology
|
| O: 0.06%
H: 1.66%
C: -2.56%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: -0.15%
H: 0.6%
C: -0.34%
t-cell collaboration
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
Published: 2024-03-05 (Crawled : 14:30) - biospace.com/
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.21%
H: 0.84%
C: 0.81%
ceo bay sciences
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Published: 2024-02-28 (Crawled : 22:00) - globenewswire.com
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.85%
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
year update financial results
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published: 2024-02-28 (Crawled : 21:00) - prnewswire.com
ACLX | $55.43 6.6% 160K
|
|
| O: 3.09%
H: 0.94%
C: -5.16%
GILD | $67.36 0.61% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.85%
business financial results
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.